Corteva initiated with an Overweight at Wells Fargo

Wells Fargo analyst Richard Garchitorena initiated coverage of Corteva with an Overweight rating and $78 price target. Garchitorena is encouraged by the company’s 2025 financial targets, introduced at its recent investor day with a new management team in place, the analyst tells investors in a research note. He thinks the 2025 financial targets are achievable and realistic, driving double digit EPS growth and margin expansion over the next several years.